NEJM - Covid-19 — A Reminder to Reason

NEJM - Covid-19 — A Reminder to Reason

The New England Journal of MedicineHow long will this pandemic last? When will we find a treatment or vaccine? Which drug should we give our patients? Will we run out of personal protective equipment (PPE)? When will everyone return to work? We...
THE LANCET - What policy makers need to know about COVID-19 protective immunity

THE LANCET - What policy makers need to know about COVID-19 protective immunity

About a third of the world is under lockdown as a public health measure to curb the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19).
NCBI - Neonatal Resuscitation Where the Mother Has a Suspected or Confirmed Novel Coronavirus (SARS-CoV-2) Infection: Suggestion for a Pragmatic Action Plan

NCBI - Neonatal Resuscitation Where the Mother Has a Suspected or Confirmed Novel Coronavirus (SARS-CoV-2) Infection: Suggestion for a Pragmatic Action Plan

National Center for Biotechnology InformationCoronavirus disease 2019 (COVID-19), caused by the novel SARS-CoV-2 virus, is rapidly spreading across the world. As the number of infections increases, those of infected pregnant women and children...
WHO - Strengthening Preparedness for COVID-19 in Cities and Urban Settings

WHO - Strengthening Preparedness for COVID-19 in Cities and Urban Settings

World Health OrganizationThis document is to support local authorities, leaders and policy-makers in cities and other urban settlements in identifying effective approaches and implementing recommended actions that enhance the prevention,...
JPIDS - Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2

JPIDS - Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2

Journal of the Pediatric Infectious Diseases SocietyAlthough Coronavirus Disease 2019 (COVID-19) is mild in nearly all children, a small proportion of pediatric patients develops severe or critical illness. Guidance is therefore needed regarding...
NIH - COVID-19 Treatment Guidelines

NIH - COVID-19 Treatment Guidelines

National Institutes of HeatlhThese Treatment Guidelines have been developed to inform clinicians how to care for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines...
JAMA - Management of COVID-19 Respiratory Distress

JAMA - Management of COVID-19 Respiratory Distress

JAMA NETWORKAcute respiratory distress syndrome (ARDS) can originate from either the gas or vascular side of the alveolus. Although the portal for coronavirus disease 2019 (COVID-19) is inhalational, and alveolar infiltrates are commonly found on...
JAMA - Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

JAMA - Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

JAMA NETWORK

How safe and effective are 2 different regimens of chloroquine diphosphate in the treatment of severe coronavirus disease 2019 (COVID-19)?

JAMA - Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death

JAMA - Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death

JAMA NetworkAmong patients with hypertension, do those taking angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) have greater illness severity or increased risk of mortality during hospitalization for...
WHO - "Immunity passports" in the context of COVID-19

WHO - "Immunity passports" in the context of COVID-19

World Health Organization
There is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection.
JAMA - Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection

JAMA - Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection

JAMA NetworkSince December 2019, a pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally.1 A spectrum of disease severity has been reported, with main...
JAMA - Stopping the Spread of COVID-19

JAMA - Stopping the Spread of COVID-19

JAMA NetworkCOVID-19 is a respiratory infection caused by the virus SARS-CoV-2, which was recently discovered after an outbreak began in Wuhan, China, in December 2019. SARS-CoV-2 is a type of coronavirus, which is a large family of viruses that...
JAMA - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and AdolescentsA Systematic Review

JAMA - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and AdolescentsA Systematic Review

JAMA NETWORK

What are the clinical features of pediatric patients with coronavirus disease 2019 (COVID-19)?

NEJM - Late-Onset Neonatal Sepsis in a Patient with Covid-19

NEJM - Late-Onset Neonatal Sepsis in a Patient with Covid-19

The New England Journal of MedicineA 3-week-old boy presented with a 2-day history of nasal congestion, tachypnea, and reduced feeding. He was born at 36 weeks of gestation to a 21-year-old woman (gravida 3, para 1) who had received antenatal...
ECDC - Infographic: COVID-19 contact tracing Infographic

ECDC - Infographic: COVID-19 contact tracing Infographic

European Centre for Disease Prevention and ControlContact tracing is a core public health response to COVID-19. Other measures include active case finding or physical distancing.
Primeiro1617181921232425Último
Categorias

Categorias

Arquivo de Notícias

Arquivo